Skip to main content
. 2024 Jun 19;208(1):89–101. doi: 10.1007/s10549-024-07403-w

Table 1.

A selection of the significantly altered pathways according to proteins affected by treatment with MZ1 in MDA-MB-231

Pathway name p-value FDR
Interleukin-4 and interleukin-13 signaling 1.11e−16 2.32e−14
Interleukin-10 signaling 3.20e−14 3.33e−12
ERBB2 Activates PTK6 signaling 1.02e−10 4.65e−09
Constitutive signaling by aberrant PI3K 1.22e−10 4.65e−09
ERBB2 Regulates cell motility 1.41e−10 4.78e−09
PIP3 Activates AKT signaling 1.95e−10 6.24e−09

Results are sorted according to p-value